Madrigal Pharmaceuticals, Inc. MDGL Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s intangibles (net)?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported intangibles (net) of $7.28M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s intangibles (net) changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s intangibles (net) increased by 57.0% year-over-year, from $4.64M to $7.28M.
- What does intangibles (net) mean?
- The value of non-physical assets like patents and licenses, after accounting for their usage over time.
- How do you interpret intangibles (net)?
- An increase typically signals strategic acquisitions or the capitalization of development costs, while a decrease reflects ongoing amortization.
- How does intangibles (net) compare across companies?
- Highly variable depending on the company's history of M&A and internal versus external R&D strategies.